{"SPADE_UN_15294": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15294", "Peptide Name": "PTP6", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "FLKLLKKLAAKFL", "Sequence Length": 13, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:PC-3 (IC50=13.27 ± 4.27 µg/ml); A549 (IC50=13.94 ± 3.96 µg/ml); Hep 3B (IC50=15.07 ± 1.59 µg/ml); MCF-7 (IC50=17.56 ± 6.23 µg/ml)", "Hemolytic Activity": "Human RBCs:less than 6% hemolysis at 100 μg/ml", "Cytotoxicity": "HEK293:IC50=14.00 ± 1.46 µg/ml", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C78H133N17O14", "Mass": 1533.0, "PI": 10.48, "Net Charge": 4, "Hydrophobicity": 0.97, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines", "Pubmed ID": "14499271", "Reference": "Peptides. 2003 Jul;24(7)945-53.", "Author": "Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=14499271"}], "Frequent Amino Acids": "LKA", "Absent Amino Acids": "CDEGHIMNOPQRSTUVWY", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 6, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_12465", "Similarity": 1.0, "Sequence": "FLKLLKKLA"}, {"SPADE_ID": "SPADE_UN_11014", "Similarity": 1.0, "Sequence": "LTLGEFLKL"}, {"SPADE_ID": "SPADE_UN_11015", "Similarity": 1.0, "Sequence": "ELTLGEFLKL"}]}}}